★ Popular

IN-VITRO RESEARCH ONLY — NOT FOR HUMAN USE

Peptides. Deep DiveResearch-based Podcast

ALLUVI Retatrutide 40 mg PenAll research episodesListen

★★★★★Rated: 4.8/5

Trusted by customers with 4.8/5 average rating.

ALLUVI Retatrutide 40 mg Pen

Name: ALLUVI Retatrutide 40 mg Pen
Brand: 77 Peptides
Price: 249.99 USD
Availability: InStock

★★★★★Trusted by customers with 4.8/5 average rating.

$249.99

Retatrutide (LY3437943) is an investigational peptide studied for activity at GIP, GLP-1 and glucagon receptors. The ALLUVI HEALTHCARE presentation is labeled 40 mg (4 doses of 10 mg) and is marked for refrigerated storage at 2°C–8°C. Published compound research does not establish the composition, purity or performance of this branded presentation.
For laboratory research use only. Not for human or veterinary use.

Buy 2+ for $242.49 each and save 3%
Buy 3+ for $237.49 each and save 5%
Buy 5+ for $224.99 each and save 10%
Buy 10+ for $212.49 each and save 15%

Size:

Direct from manufacturer to researcher

Shipping options confirmed at checkout

For laboratory research only

RESEARCHERS ALSO VIEWED

GHK-Cu

Explore the companion research collection.

View product

Characteristics

Brand	ALLUVI HEALTHCARE
Presentation	Retatrutide pen and box
Label amount	40 mg (4 × 10 mg)
Storage label	2°C–8°C
Research compound	Retatrutide (LY3437943)
CAS Number	2381089-83-2
Molecular Formula	C221H342N46O68
Molar Mass	4731.34 g/mol
Receptor targets	GIP, GLP-1 and glucagon
Status	Investigational; not an approved medicine
Batch documentation	Product-specific COA, formulation and storage conditions pending confirmation

How does ALLUVI Retatrutide 40 mg Pen work?

Published research describes retatrutide as a triple-hormone-receptor agonist targeting glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon receptors. These findings describe the investigational molecule, not verified results for the ALLUVI pen.

Handling & Safety

For laboratory research only. Not for human or veterinary use. Do not use the packaging illustration as administration, dosing or storage guidance. Obtain the product-specific safety data sheet, certificate of analysis and validated handling and storage instructions before laboratory use. Follow institutional safety procedures and wear appropriate protective equipment.

Summary

The ALLUVI HEALTHCARE 40 mg retatrutide pen presentation, listed alongside the 77 Peptides 77Reta-40 pen. Scientific references are provided below.

Certificate of Analysis (COA)

IMAGE 600 × 850 pixel

Resource

All products on this site are for research and development use only. Products are not for human consumption of any kind. Neither the statements nor the products offered are intended to diagnose, treat, cure, or prevent any disease.